Abstract
In a search for a new inhibitor of aspartyl protease, the ferrocenyl group was introduced from the C-terminus of statine to create a novel bis-statine-based peptide containing ferrocenyl moiety in solution. The target compound was characterized by infrared, 1H NMR spectroscopy, mass spectrometry, and elemental analysis.
ACKNOWLEDGMENTS
The authors thank the National Natural Science Foundation of China (No. 20572085) for financial support.